{"gene":"SOHLH2","run_date":"2026-06-10T07:46:38","timeline":{"discoveries":[{"year":2006,"finding":"SOHLH2 is a germ cell-specific basic helix-loop-helix (bHLH) transcription factor expressed in spermatogonia and oocytes of primordial and primary follicles, confined to premeiotic germ cells.","method":"Expression analysis, protein localization by immunohistochemistry in mouse gonads","journal":"Gene expression patterns : GEP","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct protein localization by IHC across developmental stages, single lab, no functional assay in this paper","pmids":["16765102"],"is_preprint":false},{"year":2008,"finding":"SOHLH2 is required for progression of differentiating type A spermatogonia into type B spermatogonia; Sohlh2-null males are infertile due to a block at differentiating type A2 spermatogonia (accumulating in M-phase prior to death), and undifferentiated spermatogonia isolated from null mice show aberrant cell-surface expression of cKit.","method":"Sohlh2 knockout mouse generation, histological analysis, immunostaining (DAZL, PLZF), cKit surface expression analysis in cultured spermatogonia","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular phenotype, multiple orthogonal methods (histology, immunostaining, cell culture), replicated by multiple labs","pmids":["18339773"],"is_preprint":false},{"year":2008,"finding":"SOHLH2 and SOHLH1 can form heterodimers; Sohlh2 null mice show downregulation of Sohlh1, and both proteins are required for differentiation of KIT+ spermatogonia and oocytes.","method":"Co-immunoprecipitation for heterodimerization; gene targeting/knockout; expression analysis of Sohlh1 in null gonads","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP for heterodimerization, KO with phenotype, single lab but orthogonal methods","pmids":["19014927"],"is_preprint":false},{"year":2011,"finding":"SOHLH1 and SOHLH2 heterodimerize with each other in vivo and also homodimerize; they are co-expressed throughout the spermatogonial population except GFRA1+ SSCs; double mutants show synergistic effects on gene expression and increased GFRA1+ population with premature meiosis; SOHLH proteins directly regulate Gfra1, Sox3, and Kit gene expression, suppressing SSC maintenance genes and inducing differentiation genes.","method":"In vivo co-immunoprecipitation; double knockout mouse; immunostaining; gene expression analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP for dimerization confirmed in vivo, double KO genetic epistasis, multiple target gene readouts, replicated across labs","pmids":["22056784"],"is_preprint":false},{"year":2011,"finding":"DNA CpG methylation in the Sohlh2 promoter region (sohlh2-P: -202 to +173 bp) dynamically changes during germ cell differentiation and correlates with Sohlh2 transcript expression, whereas methylation in first exon/intron regions remains constant.","method":"Bisulfite sequencing of promoter, exon, and intron CpG sites during gametogenesis in mouse","journal":"Molecular human reproduction","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct bisulfite sequencing of specific loci correlated with expression, single lab, no functional rescue","pmids":["21427160"],"is_preprint":false},{"year":2012,"finding":"SOHLH1 and SOHLH2 directly stimulate Kit transcription in postnatal spermatogonia by binding E-box sequences in the Kit promoter and first intron; they can independently and cooperatively bind E-box probes (EMSA); co-expression of both factors cooperatively transactivates Kit promoter and increases endogenous Kit expression in ES cells; SOHLH1 occupies the Kit promoter E-box in spermatogonia chromatin (ChIP).","method":"Transfection/promoter reporter assay, EMSA, co-immunoprecipitation, ChIP in spermatogonia, overexpression in ES cells","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (EMSA, ChIP, reporter assay, co-IP, ES cell overexpression), single lab but comprehensive mechanistic dissection","pmids":["22328502"],"is_preprint":false},{"year":2012,"finding":"BMP4/SMAD1/5/8 signaling upregulates Sohlh2 and c-kit expression in primordial follicle oocytes, promoting primordial-to-primary follicle transition and reducing oocyte apoptosis.","method":"Ovarian organ culture with BMP4, immunohistochemistry, RT-PCR, Western blotting for pSMAD1/5/8, Sohlh2, c-kit","journal":"Molecular reproduction and development","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct signaling pathway placement by inhibitor and expression studies, multiple methods, no rescue or KO in this paper","pmids":["23212987"],"is_preprint":false},{"year":2014,"finding":"The SOHLH2/SOHLH1/SP1 ternary complex auto-regulates Sohlh1 gene transcription: SOHLH2 and SOHLH1 synergistically upregulate Sohlh1 through E-boxes upstream of its promoter; SOHLH1 binds SP1; both SOHLH1 and SP1 occupy the Sohlh1 promoter in vivo in postnatal testes.","method":"Promoter reporter/transactivation assays, co-immunoprecipitation (SOHLH1-SP1 interaction), ChIP in postnatal day 8 mouse testes","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — ChIP in vivo, reporter assay, co-IP for novel SP1 interaction, multiple orthogonal methods in single study","pmids":["25003626"],"is_preprint":false},{"year":2014,"finding":"BMP4/Smad signaling induces SSC differentiation via upregulation of Sohlh2, which in turn upregulates c-kit; knockdown of Sohlh2 by RNAi abolishes BMP4-induced differentiation and c-kit upregulation, placing Sohlh2 downstream of BMP4/Smad and upstream of c-kit in SSC differentiation.","method":"BMP4 treatment of cultured SSCs, Dorsomorphin inhibitor, siRNA knockdown of Sohlh2, Western blot and flow cytometry for differentiation markers","journal":"Anatomical record (Hoboken, N.J. : 2007)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis established by pathway inhibitor and RNAi knockdown rescue experiments, single lab","pmids":["24591295"],"is_preprint":false},{"year":2014,"finding":"Sohlh2 functions as a tumor suppressor in epithelial ovarian cancer by directly upregulating p21 and downregulating cyclin D1 transcription; p21 knockdown reverses the anti-proliferative effect of Sohlh2 overexpression, and cyclin D1 knockdown reverses the pro-proliferative effect of Sohlh2 ablation.","method":"Forced expression/knockdown of Sohlh2, MTT/BrdU/colony assays, tumor xenograft, p21 and cyclin D1 siRNA epistasis experiments","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis via siRNA rescue, in vivo xenograft, multiple proliferation assays, single lab","pmids":["24858206"],"is_preprint":false},{"year":2015,"finding":"SOHLH1 and SOHLH2 directly and cooperatively repress STRA8 expression through two canonical E-box motifs in the Stra8 promoter, establishing a negative transcriptional regulatory link between SOHLH factors and STRA8 in premeiotic germ cells.","method":"Promoter reporter assays in cell lines, E-box mutational analysis, expression analysis in KIT+ spermatogonia","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay with E-box mutagenesis plus corroborating expression data, single lab","pmids":["25603532"],"is_preprint":false},{"year":2015,"finding":"Sohlh2 inhibits apoptosis of primordial follicle oocytes via the c-kit/PI3K/Akt/Foxo3a signaling pathway: Sohlh2 upregulates c-kit, increases phospho-Akt1 and phospho-Foxo3a (reducing nuclear Foxo3a), and the PI3K inhibitor LY294002 blocks Sohlh2's effect on Akt/Foxo3a phosphorylation.","method":"Sohlh2 siRNA and overexpression in primary oocyte cultures, Western blot for P-Akt1/Foxo3a, PI3K inhibitor LY294002 rescue, TUNEL apoptosis assay","journal":"Reproductive biomedicine online","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway placement by inhibitor rescue plus gain/loss of function with multiple molecular readouts, single lab","pmids":["25773528"],"is_preprint":false},{"year":2015,"finding":"Sohlh2 inhibits ovarian cancer cell invasion and metastasis by directly binding the MMP9 gene promoter and repressing its transcriptional activity; MMP9 knockdown blocks Sohlh2-ablation-enhanced invasion, and ectopic MMP9 expression compensates for Sohlh2's anti-invasive activity.","method":"Promoter reporter assay, ChIP/binding analysis, siRNA knockdown of MMP9, forced expression and silencing of Sohlh2, invasion assay, nude mouse metastasis model","journal":"Molecular carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP/promoter binding plus epistasis rescue experiments in vitro and in vivo, single lab","pmids":["26153894"],"is_preprint":false},{"year":2016,"finding":"SOHLH2 is essential for synaptonemal complex formation during spermatogenesis; Sohlh2-deficient spermatocytes lack synaptonemal complexes and have reduced SYCP3; SOHLH2 directly binds two E-boxes on the Sycp1 promoter and increases Sycp1 promoter activity.","method":"Sohlh2 knockout mouse, gene expression profiling, Western blot and immunostaining for SYCP3, promoter reporter assay with E-box binding analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO with clear cellular phenotype (absent synaptonemal complexes), promoter binding assay, single lab","pmids":["26869299"],"is_preprint":false},{"year":2016,"finding":"Sohlh2 suppresses epithelial-to-mesenchymal transition (EMT) and breast cancer cell migration/invasion by binding the IL-8 promoter and repressing its transcription; IL-8 knockdown blocks Sohlh2-ablation-enhanced invasion, and exogenous IL-8 neutralizes Sohlh2's anti-invasive activity.","method":"ChIP and luciferase reporter assays for IL-8 promoter, RNA-seq after Sohlh2 knockdown, IL-8 siRNA and recombinant IL-8 rescue experiments, in vivo metastasis model","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP, reporter assay, and epistasis rescue, single lab with multiple orthogonal methods","pmids":["27384482"],"is_preprint":false},{"year":2017,"finding":"SOHLH2 protein is expressed in mouse germline as early as E12.5, preceding SOHLH1 (E15.5); SOHLH2 initially localizes to the cytoplasm and translocates to the nucleus at E15.5 coinciding with SOHLH1 expression; nuclear translocation of SOHLH2 is dependent on SOHLH1. Single deficiency of Sohlh1 or Sohlh2 disrupts LHX8 and NOBOX expression in the embryonic gonad without affecting meiosis.","method":"Immunofluorescence/confocal microscopy for SOHLH2 subcellular localization in embryonic gonads; Sohlh1 knockout analysis of SOHLH2 localization; embryonic gonad Sohlh1/Sohlh2 KO expression analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct imaging of subcellular localization with genetic functional consequence (SOHLH1-dependent nuclear entry), KO epistasis for downstream targets, replicated with transgenic rescue experiments","pmids":["28504655"],"is_preprint":false},{"year":2019,"finding":"Sohlh2 inhibits breast cancer cell proliferation by suppressing the Wnt/β-catenin signaling pathway via direct upregulation of APC transcription; APC knockdown reverses the anti-proliferative effects of Sohlh2 overexpression.","method":"Sohlh2 forced expression/knockdown, MTT/BrdU/colony/cell cycle assays, tumor xenograft, APC siRNA epistasis, Western blot for β-catenin pathway components","journal":"Molecular carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis by siRNA rescue plus in vivo xenograft, multiple proliferation readouts, single lab","pmids":["30720232"],"is_preprint":false},{"year":2020,"finding":"Sohlh2 inhibits migration, invasion, and EMT of EOC cells under hypoxia through suppression of the HIF1α/CA9 signaling pathway.","method":"Sohlh2 overexpression/knockdown in EOC cell lines under hypoxia, migration/invasion assays, Western blot for HIF1α and CA9","journal":"Biological chemistry","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single method for pathway placement (expression change after OE/KD), no direct promoter binding or rescue in this paper","pmids":["31318683"],"is_preprint":false},{"year":2021,"finding":"SOHLH2 suppresses breast cancer angiogenesis by directly binding the HIF1α promoter and repressing its transcriptional activity, thereby downregulating HIF1α-mediated proangiogenic genes; HIF1α upregulation reverses SOHLH2-induced suppression of angiogenesis.","method":"ChIP and luciferase reporter assays for HIF1α promoter, SOHLH2 overexpression/knockdown in cancer cells and HUVEC co-culture, in vivo xenograft MVD analysis, HIF1α rescue experiments","journal":"Molecular cancer research : MCR","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay for direct promoter binding plus epistasis rescue in vitro and in vivo, single lab","pmids":["34158392"],"is_preprint":false},{"year":2022,"finding":"Sohlh2 functions as a tumor suppressor in renal cell carcinoma by downregulating DNMT3a, leading to demethylation and upregulation of Klotho; Sohlh2 expression positively correlates with Klotho and negatively with DNMT3a.","method":"Sohlh2 overexpression/knockdown in RCC lines, Western blot and qPCR for DNMT3a and Klotho, CCK-8 proliferation assay, in vivo xenograft, IHC in patient samples","journal":"Frontiers in oncology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — mechanism inferred primarily from expression changes after OE/KD, no direct methylation assay or ChIP for DNMT3a regulation by SOHLH2 reported in abstract, single lab","pmids":["35127476"],"is_preprint":false},{"year":2023,"finding":"SOHLH2 overexpression in macrophages promotes M2 polarization by directly binding the LXRα promoter and upregulating LXRα, ABCA1, and ABCG1 expression, disturbing membrane lipid homeostasis; E3 ubiquitin ligase TRIM21 promotes SOHLH2 ubiquitination and proteasomal degradation, suppressing M2 polarization and TNBC progression.","method":"Sohlh2 overexpression in macrophages, ChIP/reporter assay for LXRα promoter, co-IP and ubiquitination assay with TRIM21, in vivo lung metastasis model","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and ubiquitination assay with E3 ligase identification, in vivo functional validation, single lab","pmids":["38123542"],"is_preprint":false},{"year":2023,"finding":"Sohlh2 represses pulmonary fibrosis-associated oxidative stress by directly repressing p62 transcription, thereby inhibiting the p62/Keap1/Nrf2 anti-oxidative signaling pathway; Sohlh2 overexpression increases ROS and apoptosis in alveolar epithelial cells, reversed by the ROS inhibitor NAC.","method":"Type II AEC-specific Sohlh2 conditional knock-in mouse, Sohlh2 overexpression in A549 cells, ROS measurement, apoptosis assay, NAC rescue, promoter analysis for p62","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional knock-in mouse model plus cell line experiments with inhibitor rescue, direct promoter target identification, single lab","pmids":["37875506"],"is_preprint":false},{"year":2023,"finding":"Sohlh2 directly binds the LncRNA-H19 promoter and represses its transcription, suppressing colon cancer stem cell stemness and promoting differentiation via the LncRNA-H19/miR-141/β-catenin pathway; LncRNA-H19 mediates Sohlh2 effects on CSC stemness.","method":"ChIP and luciferase reporter for H19 promoter, LncRNA-H19 rescue/knockdown epistasis, in vitro and in vivo CSC assays","journal":"Molecular cancer research : MCR","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay for direct binding, epistasis rescue, in vivo validation, single lab","pmids":["36287177"],"is_preprint":false},{"year":2024,"finding":"SOHLH2 promotes hepatocellular carcinoma progression by directly binding the TGM2 promoter and enhancing its transcriptional activity, thereby promoting autophagy of HCC cells.","method":"Sohlh2 overexpression/knockdown in HCC lines, ChIP and reporter assay for TGM2 promoter, in vitro and in vivo proliferation/migration/invasion assays","journal":"Molecular carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay for direct promoter binding, in vivo validation, single lab","pmids":["39436118"],"is_preprint":false},{"year":2026,"finding":"PRMT5 mediates arginine methylation of SOHLH2 in vascular endothelial cells, promoting CUL4B-mediated ubiquitylation and degradation of SOHLH2; SOHLH2 in turn promotes Sirt1 transcription and represses NF-κB signaling, suppressing endothelial cell senescence, permeability, and TNBC trans-endothelial migration.","method":"Tissue microarray, Sohlh2 endothelial-specific knock-in mouse, co-IP for PRMT5-SOHLH2 and CUL4B interactions, ubiquitination assay, ChIP/reporter assay for Sirt1 promoter, in vivo lung metastasis model","journal":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific knock-in, in vivo model, ubiquitination assay, ChIP for direct target, co-IP for post-translational modification complex; single lab, abstracts only","pmids":["41867089"],"is_preprint":false},{"year":2026,"finding":"SOHLH2 transcriptionally activates RAD54L expression by binding its promoter, promoting homologous recombination repair of DNA double-strand breaks and conferring radioresistance in NSCLC; RAD54L overexpression rescues the suppression of HR repair caused by SOHLH2 knockdown.","method":"SOHLH2 overexpression/knockdown in NSCLC cells, ChIP/reporter assay for RAD54L promoter, HR repair assay, RAD54L rescue experiment, in vitro and in vivo radioresistance assays","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis rescue by RAD54L re-expression, ChIP for direct target, multiple functional readouts, single lab","pmids":["41535248"],"is_preprint":false}],"current_model":"SOHLH2 is a germ cell-specific bHLH transcription factor that heterodimerizes with SOHLH1 (and homodimerizes), with nuclear translocation dependent on SOHLH1; together they directly bind E-boxes in target promoters to regulate Kit, Gfra1, Sox3, Sycp1, Stra8, and Sohlh1 transcription, coordinating spermatogonial differentiation and synaptonemal complex formation downstream of BMP4/Smad signaling and upstream of c-kit/PI3K/Akt/Foxo3a survival signaling; in somatic cancer contexts, SOHLH2 acts as a context-dependent transcription factor that represses oncogenic targets (MMP9, IL-8, HIF1α, cyclin D1, LXRα, H19, HIF1α/CA9) or activates tumor-suppressive targets (p21, APC, p62, Sirt1, RAD54L), and its stability is controlled by TRIM21- and CUL4B-mediated ubiquitination downstream of PRMT5-catalyzed arginine methylation."},"narrative":{"mechanistic_narrative":"SOHLH2 is a germ cell-specific basic helix-loop-helix (bHLH) transcription factor that governs premeiotic germ cell differentiation and, in somatic tissues, acts as a context-dependent transcriptional regulator of proliferation, invasion, and stress responses [PMID:16765102, PMID:18339773]. In the male germline, SOHLH2 is required for progression of differentiating type A spermatogonia to type B; its loss arrests differentiation and deranges cell-surface cKit expression [PMID:18339773]. It functions in obligate partnership with SOHLH1: the two factors heterodimerize (and SOHLH2 can homodimerize), are mutually co-expressed across the spermatogonial population, and act synergistically, with SOHLH2 nuclear translocation depending on SOHLH1 [PMID:19014927, PMID:22056784, PMID:28504655]. Together they bind E-box motifs to directly activate Kit—cooperatively transactivating its promoter and first intron—and to auto-regulate Sohlh1 transcription through a ternary complex with SP1, while repressing the SSC-maintenance and meiotic-entry programs by suppressing Gfra1, Sox3, and Stra8 [PMID:22056784, PMID:22328502, PMID:25003626, PMID:25603532]. SOHLH2 acts downstream of BMP4/SMAD signaling and upstream of cKit, and protects oocytes from apoptosis via a cKit/PI3K/Akt/Foxo3a axis [PMID:23212987, PMID:24591295, PMID:25773528]. SOHLH2 is also essential for synaptonemal complex formation, directly binding and activating the Sycp1 promoter [PMID:26869299]. In cancer and somatic disease contexts, SOHLH2 binds target promoters to repress oncogenic and pro-invasive genes—MMP9, IL-8, HIF1α, cyclin D1, LXRα, H19—and to activate tumor-suppressive genes including p21 and APC, with epistasis confirming these targets mediate its anti-proliferative, anti-invasive, and anti-angiogenic effects [PMID:24858206, PMID:26153894, PMID:27384482, PMID:30720232, PMID:34158392, PMID:36287177]. SOHLH2 protein abundance is set by ubiquitin-mediated degradation, with TRIM21 and PRMT5-directed CUL4B promoting its turnover [PMID:38123542, PMID:41867089].","teleology":[{"year":2006,"claim":"Established SOHLH2's identity and expression niche, defining it as a germ cell-restricted bHLH factor confined to premeiotic spermatogonia and oocytes.","evidence":"Expression analysis and IHC across mouse gonad development","pmids":["16765102"],"confidence":"Medium","gaps":["No functional assay or target genes in this study","DNA-binding activity not demonstrated"]},{"year":2008,"claim":"Defined the in vivo requirement for SOHLH2 in spermatogonial differentiation, showing knockout males arrest at type A2 spermatogonia with aberrant cKit, linking the factor to the cKit differentiation program.","evidence":"Sohlh2 knockout mouse with histology, marker immunostaining, and cultured spermatogonia cKit analysis","pmids":["18339773"],"confidence":"High","gaps":["Direct transcriptional targets not yet identified","Mechanism of cKit deregulation unresolved at this stage"]},{"year":2008,"claim":"Identified SOHLH1 as a SOHLH2 partner and showed SOHLH2 controls Sohlh1 levels, introducing the heterodimer model for KIT+ germ cell differentiation.","evidence":"Co-IP for heterodimerization, knockout, and Sohlh1 expression analysis","pmids":["19014927"],"confidence":"Medium","gaps":["Direct promoter binding not shown","Whether dimerization is required for DNA binding unresolved"]},{"year":2011,"claim":"Resolved the dimerization architecture and the dual regulatory logic, demonstrating in vivo hetero- and homodimerization and direct, synergistic regulation of Gfra1, Sox3, and Kit to suppress SSC maintenance and induce differentiation.","evidence":"In vivo reciprocal co-IP, double-knockout genetic epistasis, immunostaining, and gene expression analysis","pmids":["22056784"],"confidence":"High","gaps":["E-box occupancy at Gfra1/Sox3 not directly mapped here","Repression versus activation mechanism not biochemically distinguished"]},{"year":2011,"claim":"Showed SOHLH2 transcription is itself epigenetically gated, with dynamic promoter CpG methylation tracking its expression during gametogenesis.","evidence":"Bisulfite sequencing of promoter/exon/intron loci correlated with transcript levels","pmids":["21427160"],"confidence":"Medium","gaps":["Causal link between methylation and expression not tested by functional rescue","Enzymes establishing the methylation not identified"]},{"year":2012,"claim":"Provided direct biochemical proof that SOHLH1/SOHLH2 bind Kit promoter and intronic E-boxes and cooperatively transactivate Kit, establishing Kit as a bona fide direct target.","evidence":"Reporter assays, EMSA, ChIP in spermatogonia, co-IP, and ES cell overexpression","pmids":["22328502"],"confidence":"High","gaps":["Independent versus cooperative contributions of each factor not fully separated","Co-activator requirements not defined"]},{"year":2012,"claim":"Placed SOHLH2 within an upstream BMP4/SMAD signaling input controlling the primordial-to-primary follicle transition.","evidence":"Ovarian organ culture with BMP4, IHC, RT-PCR, and pSMAD Western blotting","pmids":["23212987"],"confidence":"Medium","gaps":["No knockout or rescue in this system","Direct SMAD action on the Sohlh2 promoter not demonstrated"]},{"year":2014,"claim":"Uncovered an auto-regulatory loop in which SOHLH2/SOHLH1 and SP1 form a ternary complex to activate Sohlh1 transcription, explaining mutual dependence of the two factors.","evidence":"Reporter/transactivation assays, SOHLH1-SP1 co-IP, and in vivo ChIP in postnatal testes","pmids":["25003626"],"confidence":"High","gaps":["Whether SOHLH2 contacts SP1 directly not resolved","Stoichiometry of the ternary complex unknown"]},{"year":2014,"claim":"Confirmed the BMP4/Smad → Sohlh2 → cKit epistatic order in SSC differentiation through pathway inhibition and RNAi.","evidence":"BMP4 treatment, dorsomorphin inhibition, and Sohlh2 siRNA in cultured SSCs","pmids":["24591295"],"confidence":"Medium","gaps":["Direct transcriptional connection to cKit in SSCs not re-mapped here","In vivo relevance of the inhibitor effect untested"]},{"year":2014,"claim":"Opened the somatic/oncogenic chapter, defining SOHLH2 as an ovarian cancer tumor suppressor acting through direct p21 upregulation and cyclin D1 downregulation.","evidence":"Gain/loss of function, proliferation assays, xenografts, and p21/cyclin D1 siRNA epistasis","pmids":["24858206"],"confidence":"Medium","gaps":["Direct promoter occupancy at p21/cyclin D1 not shown here","Mechanism switching SOHLH2 between activation and repression unknown"]},{"year":2015,"claim":"Extended the germline regulatory network by showing SOHLH factors cooperatively repress Stra8 via E-boxes, linking them to control of meiotic entry timing.","evidence":"Reporter assays with E-box mutagenesis and expression analysis in KIT+ spermatogonia","pmids":["25603532"],"confidence":"Medium","gaps":["In vivo ChIP at the Stra8 promoter not reported","Repressive co-factors not identified"]},{"year":2015,"claim":"Defined the survival pathway by which SOHLH2 protects oocytes, the cKit/PI3K/Akt/Foxo3a anti-apoptotic axis.","evidence":"siRNA/overexpression in oocyte cultures, P-Akt/Foxo3a Western blots, LY294002 rescue, and TUNEL","pmids":["25773528"],"confidence":"Medium","gaps":["Direct transcriptional step linking SOHLH2 to this axis assumed via cKit","In vivo ovarian relevance not tested in this study"]},{"year":2015,"claim":"Showed SOHLH2 suppresses cancer invasion through direct repression of MMP9, the first promoter-level anti-invasive target.","evidence":"Reporter/binding assays, MMP9 siRNA and ectopic MMP9 epistasis, invasion assays, and metastasis model","pmids":["26153894"],"confidence":"Medium","gaps":["Co-repressor machinery undefined","Single-cancer-type validation"]},{"year":2016,"claim":"Identified an independent meiotic role for SOHLH2 in synaptonemal complex formation through direct activation of Sycp1.","evidence":"Knockout phenotyping, SYCP3 immunostaining/Western, and Sycp1 promoter reporter with E-box analysis","pmids":["26869299"],"confidence":"Medium","gaps":["Whether SOHLH1 partnership is required here not resolved","Direct regulation of other SC components not tested"]},{"year":2016,"claim":"Expanded anti-invasive function to breast cancer EMT via direct repression of IL-8.","evidence":"ChIP, luciferase reporter, RNA-seq, IL-8 siRNA/recombinant IL-8 rescue, and metastasis model","pmids":["27384482"],"confidence":"Medium","gaps":["Cross-talk among repressed invasion targets not integrated","Determinants of target selectivity unknown"]},{"year":2017,"claim":"Established SOHLH1-dependent nuclear translocation of SOHLH2 and defined its earliest embryonic germline activity, refining the temporal hierarchy of the two factors.","evidence":"Confocal localization in embryonic gonads, Sohlh1 KO localization analysis, and KO expression of LHX8/NOBOX","pmids":["28504655"],"confidence":"High","gaps":["Molecular basis of SOHLH1-dependent nuclear import unknown","Whether cytoplasmic SOHLH2 has non-genomic roles untested"]},{"year":2019,"claim":"Showed SOHLH2 restrains Wnt/β-catenin signaling by directly activating APC, adding a tumor-suppressive activation target.","evidence":"Forced expression/knockdown, proliferation/cell-cycle assays, xenograft, and APC siRNA epistasis","pmids":["30720232"],"confidence":"Medium","gaps":["Direct APC promoter occupancy not shown","Reconciliation with H19/β-catenin pathway in colon cancer not addressed"]},{"year":2020,"claim":"Linked SOHLH2 to hypoxic invasion control via the HIF1α/CA9 axis in ovarian cancer.","evidence":"Overexpression/knockdown under hypoxia with migration/invasion assays and HIF1α/CA9 Western blot","pmids":["31318683"],"confidence":"Low","gaps":["No direct promoter binding or rescue in this study","Pathway placement rests on expression changes only"]},{"year":2021,"claim":"Provided direct evidence that SOHLH2 represses angiogenesis by binding and repressing the HIF1α promoter.","evidence":"ChIP, luciferase reporter, HUVEC co-culture, xenograft MVD, and HIF1α rescue","pmids":["34158392"],"confidence":"Medium","gaps":["Relationship to HIF1α/CA9 invasion findings not unified","Hypoxia-dependence of SOHLH2 binding untested"]},{"year":2022,"claim":"Proposed an epigenetic tumor-suppressive route in renal cancer via DNMT3a downregulation and Klotho demethylation.","evidence":"Overexpression/knockdown in RCC lines, DNMT3a/Klotho qPCR-Western, proliferation, xenograft, and patient IHC","pmids":["35127476"],"confidence":"Low","gaps":["No direct methylation assay or ChIP for DNMT3a regulation","Mechanism inferred from expression correlation"]},{"year":2023,"claim":"Connected SOHLH2 to tumor immune microenvironment, showing it drives macrophage M2 polarization via direct LXRα activation, and identified TRIM21 as an E3 ligase controlling SOHLH2 turnover.","evidence":"Macrophage overexpression, ChIP/reporter for LXRα, TRIM21 co-IP and ubiquitination assays, and lung metastasis model","pmids":["38123542"],"confidence":"Medium","gaps":["Degron and ubiquitination sites on SOHLH2 not mapped","Reconciliation with tumor-suppressive roles context-dependent and unexplained"]},{"year":2023,"claim":"Demonstrated SOHLH2 modulates oxidative stress in pulmonary fibrosis by directly repressing p62 and dampening Keap1/Nrf2 signaling.","evidence":"Type II AEC conditional knock-in mouse, A549 overexpression, ROS/apoptosis assays, NAC rescue, and p62 promoter analysis","pmids":["37875506"],"confidence":"Medium","gaps":["Direct ChIP at the p62 promoter not detailed","Relevance beyond AEC unknown"]},{"year":2023,"claim":"Showed SOHLH2 suppresses cancer stem cell stemness by directly repressing the LncRNA-H19 promoter, feeding the H19/miR-141/β-catenin axis.","evidence":"ChIP, luciferase reporter, H19 rescue/knockdown epistasis, and in vitro/in vivo CSC assays","pmids":["36287177"],"confidence":"Medium","gaps":["Integration with APC-mediated Wnt control not addressed","Determinants of repression vs activation at different promoters unknown"]},{"year":2024,"claim":"Documented a pro-tumorigenic activity in hepatocellular carcinoma, with SOHLH2 directly activating TGM2 to promote autophagy and progression, underscoring context dependence.","evidence":"Overexpression/knockdown, ChIP/reporter for TGM2, and in vitro/in vivo tumor assays","pmids":["39436118"],"confidence":"Medium","gaps":["Basis for tumor-promoting versus tumor-suppressing switch unresolved","Upstream control of SOHLH2 in HCC undefined"]},{"year":2026,"claim":"Defined post-translational control of SOHLH2 by PRMT5-directed arginine methylation and CUL4B-mediated degradation, coupled to a Sirt1-activating, NF-κB-repressing endothelial program.","evidence":"Endothelial knock-in mouse, PRMT5/CUL4B co-IP, ubiquitination assay, Sirt1 ChIP/reporter, and lung metastasis model","pmids":["41867089"],"confidence":"Medium","gaps":["Methylated arginine residues not mapped","Interplay between TRIM21 and CUL4B degradation routes unresolved"]},{"year":2026,"claim":"Linked SOHLH2 to DNA double-strand break repair, showing it activates RAD54L to promote homologous recombination and radioresistance in lung cancer.","evidence":"Overexpression/knockdown, ChIP/reporter for RAD54L, HR repair assay, RAD54L rescue, and radioresistance models","pmids":["41535248"],"confidence":"Medium","gaps":["Whether HR role extends to germ cell meiotic recombination untested","Relationship to SOHLH2 degradation control unexamined"]},{"year":null,"claim":"The molecular determinant that switches SOHLH2 between direct transcriptional activation and repression, and between tumor-suppressive and tumor-promoting outputs across tissues, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of SOHLH2 DNA binding or cofactor selection","Co-activator/co-repressor partners that dictate target outcome unidentified","Integration of TRIM21 and PRMT5/CUL4B degradation pathways into a unified stability model lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,3,5,7,9,12,14,18,22,23,25]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[5,7,10,13,18,22]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,15]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[15]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[5,7,9,12,14,18,22,23,25]},{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[1,3,13]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,8,11,16]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,15]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[9,12,14,18,20,24]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[25]}],"complexes":["SOHLH1-SOHLH2 heterodimer","SOHLH2/SOHLH1/SP1 ternary complex"],"partners":["SOHLH1","SP1","TRIM21","PRMT5","CUL4B"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NX45","full_name":"Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2","aliases":[],"length_aa":425,"mass_kda":46.9,"function":"Transcription regulator of both male and female germline differentiation. Suppresses genes involved in spermatogonial stem cells maintenance, and induces genes important for spermatogonial differentiation. Coordinates oocyte differentiation without affecting meiosis I (By similarity)","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q9NX45/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SOHLH2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SOHLH2","total_profiled":1310},"omim":[{"mim_id":"616066","title":"SPERMATOGENESIS- AND OOGENESIS-SPECIFIC BASIC HELIX-LOOP-HELIX PROTEIN 2; SOHLH2","url":"https://www.omim.org/entry/616066"},{"mim_id":"610224","title":"SPERMATOGENESIS- AND OOGENESIS-SPECIFIC BASIC HELIX-LOOP-HELIX PROTEIN 1; SOHLH1","url":"https://www.omim.org/entry/610224"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Vesicles","reliability":"Uncertain"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"testis","ntpm":25.8}],"url":"https://www.proteinatlas.org/search/SOHLH2"},"hgnc":{"alias_symbol":["FLJ20449","TEB1","bHLHe81","SPATA28"],"prev_symbol":[]},"alphafold":{"accession":"Q9NX45","domains":[{"cath_id":"3.40.50.2300","chopping":"18-139","consensus_level":"high","plddt":82.1481,"start":18,"end":139},{"cath_id":"4.10.280,4.10.280","chopping":"198-271","consensus_level":"high","plddt":84.6661,"start":198,"end":271}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NX45","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NX45-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NX45-F1-predicted_aligned_error_v6.png","plddt_mean":57.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SOHLH2","jax_strain_url":"https://www.jax.org/strain/search?query=SOHLH2"},"sequence":{"accession":"Q9NX45","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NX45.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NX45/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NX45"}},"corpus_meta":[{"pmid":"22056784","id":"PMC_22056784","title":"SOHLH1 and SOHLH2 coordinate spermatogonial differentiation.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22056784","citation_count":150,"is_preprint":false},{"pmid":"16765102","id":"PMC_16765102","title":"Sohlh2 is a germ cell-specific bHLH transcription factor.","date":"2006","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/16765102","citation_count":85,"is_preprint":false},{"pmid":"18339773","id":"PMC_18339773","title":"Sohlh2 knockout mice are male-sterile because of degeneration of differentiating type A spermatogonia.","date":"2008","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/18339773","citation_count":76,"is_preprint":false},{"pmid":"19014927","id":"PMC_19014927","title":"Sohlh2 affects differentiation of KIT positive oocytes and spermatogonia.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19014927","citation_count":72,"is_preprint":false},{"pmid":"22328502","id":"PMC_22328502","title":"SOHLH1 and SOHLH2 control Kit expression during postnatal male germ cell development.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/22328502","citation_count":71,"is_preprint":false},{"pmid":"28504655","id":"PMC_28504655","title":"Transcription factors SOHLH1 and SOHLH2 coordinate oocyte differentiation without affecting meiosis I.","date":"2017","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/28504655","citation_count":54,"is_preprint":false},{"pmid":"24524832","id":"PMC_24524832","title":"Novel variants in the SOHLH2 gene are implicated in human premature ovarian failure.","date":"2014","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/24524832","citation_count":43,"is_preprint":false},{"pmid":"38123542","id":"PMC_38123542","title":"TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/38123542","citation_count":41,"is_preprint":false},{"pmid":"23212987","id":"PMC_23212987","title":"Effects of BMP4/SMAD signaling pathway on mouse primordial follicle growth and survival via up-regulation of Sohlh2 and c-kit.","date":"2012","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/23212987","citation_count":35,"is_preprint":false},{"pmid":"24591295","id":"PMC_24591295","title":"BMP4/Smad signaling pathway induces the differentiation of mouse spermatogonial stem cells via upregulation of Sohlh2.","date":"2014","source":"Anatomical record (Hoboken, N.J. : 2007)","url":"https://pubmed.ncbi.nlm.nih.gov/24591295","citation_count":32,"is_preprint":false},{"pmid":"22143754","id":"PMC_22143754","title":"Structural basis for Tetrahymena telomerase processivity factor Teb1 binding to single-stranded telomeric-repeat DNA.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22143754","citation_count":31,"is_preprint":false},{"pmid":"21427160","id":"PMC_21427160","title":"DNA methylation of germ-cell-specific basic helix-loop-helix (HLH) transcription factors, Sohlh2 and Figlα during gametogenesis.","date":"2011","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/21427160","citation_count":29,"is_preprint":false},{"pmid":"24858206","id":"PMC_24858206","title":"Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1.","date":"2014","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/24858206","citation_count":28,"is_preprint":false},{"pmid":"25003626","id":"PMC_25003626","title":"Auto-regulation of the Sohlh1 gene by the SOHLH2/SOHLH1/SP1 complex: implications for early spermatogenesis and oogenesis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25003626","citation_count":22,"is_preprint":false},{"pmid":"37875506","id":"PMC_37875506","title":"Sohlh2 promotes pulmonary fibrosis via repression of p62/Keap1/Nrf2 mediated anti-oxidative signaling pathway.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37875506","citation_count":22,"is_preprint":false},{"pmid":"26153894","id":"PMC_26153894","title":"Sohlh2 inhibits human ovarian cancer cell invasion and metastasis by transcriptional inactivation of MMP9.","date":"2015","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/26153894","citation_count":20,"is_preprint":false},{"pmid":"25225329","id":"PMC_25225329","title":"Direct single-stranded DNA binding by Teb1 mediates the recruitment of Tetrahymena thermophila telomerase to telomeres.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25225329","citation_count":18,"is_preprint":false},{"pmid":"25603532","id":"PMC_25603532","title":"SOHLH1 and SOHLH2 directly down-regulate STIMULATED BY RETINOIC ACID 8 (STRA8) expression.","date":"2015","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/25603532","citation_count":17,"is_preprint":false},{"pmid":"25773528","id":"PMC_25773528","title":"Sohlh2 inhibits the apoptosis of mouse primordial follicle oocytes via C-kit/PI3K/Akt/Foxo3a signalling pathway.","date":"2015","source":"Reproductive biomedicine online","url":"https://pubmed.ncbi.nlm.nih.gov/25773528","citation_count":17,"is_preprint":false},{"pmid":"30720232","id":"PMC_30720232","title":"Sohlh2 inhibits breast cancer cell proliferation by suppressing Wnt/β-catenin signaling pathway.","date":"2019","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/30720232","citation_count":16,"is_preprint":false},{"pmid":"23314747","id":"PMC_23314747","title":"Myb-domain protein Teb1 controls histone levels and centromere assembly in fission yeast.","date":"2013","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/23314747","citation_count":15,"is_preprint":false},{"pmid":"34158392","id":"PMC_34158392","title":"SOHLH2 Suppresses Angiogenesis by Downregulating HIF1α Expression in Breast Cancer.","date":"2021","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/34158392","citation_count":14,"is_preprint":false},{"pmid":"26869299","id":"PMC_26869299","title":"SOHLH2 is essential for synaptonemal complex formation during spermatogenesis in early postnatal mouse testes.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26869299","citation_count":14,"is_preprint":false},{"pmid":"26375665","id":"PMC_26375665","title":"Immunohistochemical Study of Expression of Sohlh1 and Sohlh2 in Normal Adult Human Tissues.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26375665","citation_count":11,"is_preprint":false},{"pmid":"33875642","id":"PMC_33875642","title":"Germline variants at SOHLH2 influence multiple myeloma risk.","date":"2021","source":"Blood cancer journal","url":"https://pubmed.ncbi.nlm.nih.gov/33875642","citation_count":11,"is_preprint":false},{"pmid":"25463635","id":"PMC_25463635","title":"Association of genetic variants in SOHLH1 and SOHLH2 with non-obstructive azoospermia risk in the Chinese population.","date":"2014","source":"European journal of obstetrics, gynecology, and reproductive biology","url":"https://pubmed.ncbi.nlm.nih.gov/25463635","citation_count":10,"is_preprint":false},{"pmid":"27384482","id":"PMC_27384482","title":"Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27384482","citation_count":8,"is_preprint":false},{"pmid":"32690270","id":"PMC_32690270","title":"Intronic variation of the SOHLH2 gene confers risk to male reproductive impairment.","date":"2020","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/32690270","citation_count":8,"is_preprint":false},{"pmid":"36287177","id":"PMC_36287177","title":"Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription.","date":"2023","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/36287177","citation_count":7,"is_preprint":false},{"pmid":"31318683","id":"PMC_31318683","title":"Sohlh2 alleviates malignancy of EOC cells under hypoxia via inhibiting the HIF1α/CA9 signaling pathway.","date":"2020","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31318683","citation_count":6,"is_preprint":false},{"pmid":"35127476","id":"PMC_35127476","title":"Sohlh2 Inhibits the Malignant Progression of Renal Cell Carcinoma by Upregulating Klotho via DNMT3a.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35127476","citation_count":4,"is_preprint":false},{"pmid":"39436118","id":"PMC_39436118","title":"Sohlh2 Promotes the Progression of Hepatocellular Carcinoma via TGM2-Mediated Autophagy.","date":"2024","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/39436118","citation_count":2,"is_preprint":false},{"pmid":"41867089","id":"PMC_41867089","title":"PRMT5/Sohlh2/Sirt1 Signaling Pathway in Vascular Endothelial Cells Modulates Lung Metastasis of Triple-Negative Breast Cancer.","date":"2026","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41867089","citation_count":0,"is_preprint":false},{"pmid":"41535248","id":"PMC_41535248","title":"SOHLH2-RAD54L axis induces radioresistance by promoting homologous recombination repair in non-small cell lung cancer.","date":"2026","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/41535248","citation_count":0,"is_preprint":false},{"pmid":"41775083","id":"PMC_41775083","title":"Sohlh2 inhibited the angiogenesis of hepatocellular carcinoma through the HIF-1α/VEGFA pathway.","date":"2026","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41775083","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19920,"output_tokens":6628,"usd":0.07959,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15529,"output_tokens":7129,"usd":0.127935,"stage2_stop_reason":"end_turn"},"total_usd":0.207525,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"SOHLH2 is a germ cell-specific basic helix-loop-helix (bHLH) transcription factor expressed in spermatogonia and oocytes of primordial and primary follicles, confined to premeiotic germ cells.\",\n      \"method\": \"Expression analysis, protein localization by immunohistochemistry in mouse gonads\",\n      \"journal\": \"Gene expression patterns : GEP\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct protein localization by IHC across developmental stages, single lab, no functional assay in this paper\",\n      \"pmids\": [\"16765102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SOHLH2 is required for progression of differentiating type A spermatogonia into type B spermatogonia; Sohlh2-null males are infertile due to a block at differentiating type A2 spermatogonia (accumulating in M-phase prior to death), and undifferentiated spermatogonia isolated from null mice show aberrant cell-surface expression of cKit.\",\n      \"method\": \"Sohlh2 knockout mouse generation, histological analysis, immunostaining (DAZL, PLZF), cKit surface expression analysis in cultured spermatogonia\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular phenotype, multiple orthogonal methods (histology, immunostaining, cell culture), replicated by multiple labs\",\n      \"pmids\": [\"18339773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SOHLH2 and SOHLH1 can form heterodimers; Sohlh2 null mice show downregulation of Sohlh1, and both proteins are required for differentiation of KIT+ spermatogonia and oocytes.\",\n      \"method\": \"Co-immunoprecipitation for heterodimerization; gene targeting/knockout; expression analysis of Sohlh1 in null gonads\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP for heterodimerization, KO with phenotype, single lab but orthogonal methods\",\n      \"pmids\": [\"19014927\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SOHLH1 and SOHLH2 heterodimerize with each other in vivo and also homodimerize; they are co-expressed throughout the spermatogonial population except GFRA1+ SSCs; double mutants show synergistic effects on gene expression and increased GFRA1+ population with premature meiosis; SOHLH proteins directly regulate Gfra1, Sox3, and Kit gene expression, suppressing SSC maintenance genes and inducing differentiation genes.\",\n      \"method\": \"In vivo co-immunoprecipitation; double knockout mouse; immunostaining; gene expression analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP for dimerization confirmed in vivo, double KO genetic epistasis, multiple target gene readouts, replicated across labs\",\n      \"pmids\": [\"22056784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DNA CpG methylation in the Sohlh2 promoter region (sohlh2-P: -202 to +173 bp) dynamically changes during germ cell differentiation and correlates with Sohlh2 transcript expression, whereas methylation in first exon/intron regions remains constant.\",\n      \"method\": \"Bisulfite sequencing of promoter, exon, and intron CpG sites during gametogenesis in mouse\",\n      \"journal\": \"Molecular human reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct bisulfite sequencing of specific loci correlated with expression, single lab, no functional rescue\",\n      \"pmids\": [\"21427160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SOHLH1 and SOHLH2 directly stimulate Kit transcription in postnatal spermatogonia by binding E-box sequences in the Kit promoter and first intron; they can independently and cooperatively bind E-box probes (EMSA); co-expression of both factors cooperatively transactivates Kit promoter and increases endogenous Kit expression in ES cells; SOHLH1 occupies the Kit promoter E-box in spermatogonia chromatin (ChIP).\",\n      \"method\": \"Transfection/promoter reporter assay, EMSA, co-immunoprecipitation, ChIP in spermatogonia, overexpression in ES cells\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (EMSA, ChIP, reporter assay, co-IP, ES cell overexpression), single lab but comprehensive mechanistic dissection\",\n      \"pmids\": [\"22328502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BMP4/SMAD1/5/8 signaling upregulates Sohlh2 and c-kit expression in primordial follicle oocytes, promoting primordial-to-primary follicle transition and reducing oocyte apoptosis.\",\n      \"method\": \"Ovarian organ culture with BMP4, immunohistochemistry, RT-PCR, Western blotting for pSMAD1/5/8, Sohlh2, c-kit\",\n      \"journal\": \"Molecular reproduction and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct signaling pathway placement by inhibitor and expression studies, multiple methods, no rescue or KO in this paper\",\n      \"pmids\": [\"23212987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The SOHLH2/SOHLH1/SP1 ternary complex auto-regulates Sohlh1 gene transcription: SOHLH2 and SOHLH1 synergistically upregulate Sohlh1 through E-boxes upstream of its promoter; SOHLH1 binds SP1; both SOHLH1 and SP1 occupy the Sohlh1 promoter in vivo in postnatal testes.\",\n      \"method\": \"Promoter reporter/transactivation assays, co-immunoprecipitation (SOHLH1-SP1 interaction), ChIP in postnatal day 8 mouse testes\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — ChIP in vivo, reporter assay, co-IP for novel SP1 interaction, multiple orthogonal methods in single study\",\n      \"pmids\": [\"25003626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"BMP4/Smad signaling induces SSC differentiation via upregulation of Sohlh2, which in turn upregulates c-kit; knockdown of Sohlh2 by RNAi abolishes BMP4-induced differentiation and c-kit upregulation, placing Sohlh2 downstream of BMP4/Smad and upstream of c-kit in SSC differentiation.\",\n      \"method\": \"BMP4 treatment of cultured SSCs, Dorsomorphin inhibitor, siRNA knockdown of Sohlh2, Western blot and flow cytometry for differentiation markers\",\n      \"journal\": \"Anatomical record (Hoboken, N.J. : 2007)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis established by pathway inhibitor and RNAi knockdown rescue experiments, single lab\",\n      \"pmids\": [\"24591295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Sohlh2 functions as a tumor suppressor in epithelial ovarian cancer by directly upregulating p21 and downregulating cyclin D1 transcription; p21 knockdown reverses the anti-proliferative effect of Sohlh2 overexpression, and cyclin D1 knockdown reverses the pro-proliferative effect of Sohlh2 ablation.\",\n      \"method\": \"Forced expression/knockdown of Sohlh2, MTT/BrdU/colony assays, tumor xenograft, p21 and cyclin D1 siRNA epistasis experiments\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis via siRNA rescue, in vivo xenograft, multiple proliferation assays, single lab\",\n      \"pmids\": [\"24858206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SOHLH1 and SOHLH2 directly and cooperatively repress STRA8 expression through two canonical E-box motifs in the Stra8 promoter, establishing a negative transcriptional regulatory link between SOHLH factors and STRA8 in premeiotic germ cells.\",\n      \"method\": \"Promoter reporter assays in cell lines, E-box mutational analysis, expression analysis in KIT+ spermatogonia\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay with E-box mutagenesis plus corroborating expression data, single lab\",\n      \"pmids\": [\"25603532\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Sohlh2 inhibits apoptosis of primordial follicle oocytes via the c-kit/PI3K/Akt/Foxo3a signaling pathway: Sohlh2 upregulates c-kit, increases phospho-Akt1 and phospho-Foxo3a (reducing nuclear Foxo3a), and the PI3K inhibitor LY294002 blocks Sohlh2's effect on Akt/Foxo3a phosphorylation.\",\n      \"method\": \"Sohlh2 siRNA and overexpression in primary oocyte cultures, Western blot for P-Akt1/Foxo3a, PI3K inhibitor LY294002 rescue, TUNEL apoptosis assay\",\n      \"journal\": \"Reproductive biomedicine online\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway placement by inhibitor rescue plus gain/loss of function with multiple molecular readouts, single lab\",\n      \"pmids\": [\"25773528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Sohlh2 inhibits ovarian cancer cell invasion and metastasis by directly binding the MMP9 gene promoter and repressing its transcriptional activity; MMP9 knockdown blocks Sohlh2-ablation-enhanced invasion, and ectopic MMP9 expression compensates for Sohlh2's anti-invasive activity.\",\n      \"method\": \"Promoter reporter assay, ChIP/binding analysis, siRNA knockdown of MMP9, forced expression and silencing of Sohlh2, invasion assay, nude mouse metastasis model\",\n      \"journal\": \"Molecular carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP/promoter binding plus epistasis rescue experiments in vitro and in vivo, single lab\",\n      \"pmids\": [\"26153894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SOHLH2 is essential for synaptonemal complex formation during spermatogenesis; Sohlh2-deficient spermatocytes lack synaptonemal complexes and have reduced SYCP3; SOHLH2 directly binds two E-boxes on the Sycp1 promoter and increases Sycp1 promoter activity.\",\n      \"method\": \"Sohlh2 knockout mouse, gene expression profiling, Western blot and immunostaining for SYCP3, promoter reporter assay with E-box binding analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with clear cellular phenotype (absent synaptonemal complexes), promoter binding assay, single lab\",\n      \"pmids\": [\"26869299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Sohlh2 suppresses epithelial-to-mesenchymal transition (EMT) and breast cancer cell migration/invasion by binding the IL-8 promoter and repressing its transcription; IL-8 knockdown blocks Sohlh2-ablation-enhanced invasion, and exogenous IL-8 neutralizes Sohlh2's anti-invasive activity.\",\n      \"method\": \"ChIP and luciferase reporter assays for IL-8 promoter, RNA-seq after Sohlh2 knockdown, IL-8 siRNA and recombinant IL-8 rescue experiments, in vivo metastasis model\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, reporter assay, and epistasis rescue, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"27384482\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SOHLH2 protein is expressed in mouse germline as early as E12.5, preceding SOHLH1 (E15.5); SOHLH2 initially localizes to the cytoplasm and translocates to the nucleus at E15.5 coinciding with SOHLH1 expression; nuclear translocation of SOHLH2 is dependent on SOHLH1. Single deficiency of Sohlh1 or Sohlh2 disrupts LHX8 and NOBOX expression in the embryonic gonad without affecting meiosis.\",\n      \"method\": \"Immunofluorescence/confocal microscopy for SOHLH2 subcellular localization in embryonic gonads; Sohlh1 knockout analysis of SOHLH2 localization; embryonic gonad Sohlh1/Sohlh2 KO expression analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct imaging of subcellular localization with genetic functional consequence (SOHLH1-dependent nuclear entry), KO epistasis for downstream targets, replicated with transgenic rescue experiments\",\n      \"pmids\": [\"28504655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Sohlh2 inhibits breast cancer cell proliferation by suppressing the Wnt/β-catenin signaling pathway via direct upregulation of APC transcription; APC knockdown reverses the anti-proliferative effects of Sohlh2 overexpression.\",\n      \"method\": \"Sohlh2 forced expression/knockdown, MTT/BrdU/colony/cell cycle assays, tumor xenograft, APC siRNA epistasis, Western blot for β-catenin pathway components\",\n      \"journal\": \"Molecular carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis by siRNA rescue plus in vivo xenograft, multiple proliferation readouts, single lab\",\n      \"pmids\": [\"30720232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Sohlh2 inhibits migration, invasion, and EMT of EOC cells under hypoxia through suppression of the HIF1α/CA9 signaling pathway.\",\n      \"method\": \"Sohlh2 overexpression/knockdown in EOC cell lines under hypoxia, migration/invasion assays, Western blot for HIF1α and CA9\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single method for pathway placement (expression change after OE/KD), no direct promoter binding or rescue in this paper\",\n      \"pmids\": [\"31318683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SOHLH2 suppresses breast cancer angiogenesis by directly binding the HIF1α promoter and repressing its transcriptional activity, thereby downregulating HIF1α-mediated proangiogenic genes; HIF1α upregulation reverses SOHLH2-induced suppression of angiogenesis.\",\n      \"method\": \"ChIP and luciferase reporter assays for HIF1α promoter, SOHLH2 overexpression/knockdown in cancer cells and HUVEC co-culture, in vivo xenograft MVD analysis, HIF1α rescue experiments\",\n      \"journal\": \"Molecular cancer research : MCR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay for direct promoter binding plus epistasis rescue in vitro and in vivo, single lab\",\n      \"pmids\": [\"34158392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Sohlh2 functions as a tumor suppressor in renal cell carcinoma by downregulating DNMT3a, leading to demethylation and upregulation of Klotho; Sohlh2 expression positively correlates with Klotho and negatively with DNMT3a.\",\n      \"method\": \"Sohlh2 overexpression/knockdown in RCC lines, Western blot and qPCR for DNMT3a and Klotho, CCK-8 proliferation assay, in vivo xenograft, IHC in patient samples\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — mechanism inferred primarily from expression changes after OE/KD, no direct methylation assay or ChIP for DNMT3a regulation by SOHLH2 reported in abstract, single lab\",\n      \"pmids\": [\"35127476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SOHLH2 overexpression in macrophages promotes M2 polarization by directly binding the LXRα promoter and upregulating LXRα, ABCA1, and ABCG1 expression, disturbing membrane lipid homeostasis; E3 ubiquitin ligase TRIM21 promotes SOHLH2 ubiquitination and proteasomal degradation, suppressing M2 polarization and TNBC progression.\",\n      \"method\": \"Sohlh2 overexpression in macrophages, ChIP/reporter assay for LXRα promoter, co-IP and ubiquitination assay with TRIM21, in vivo lung metastasis model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and ubiquitination assay with E3 ligase identification, in vivo functional validation, single lab\",\n      \"pmids\": [\"38123542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Sohlh2 represses pulmonary fibrosis-associated oxidative stress by directly repressing p62 transcription, thereby inhibiting the p62/Keap1/Nrf2 anti-oxidative signaling pathway; Sohlh2 overexpression increases ROS and apoptosis in alveolar epithelial cells, reversed by the ROS inhibitor NAC.\",\n      \"method\": \"Type II AEC-specific Sohlh2 conditional knock-in mouse, Sohlh2 overexpression in A549 cells, ROS measurement, apoptosis assay, NAC rescue, promoter analysis for p62\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional knock-in mouse model plus cell line experiments with inhibitor rescue, direct promoter target identification, single lab\",\n      \"pmids\": [\"37875506\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Sohlh2 directly binds the LncRNA-H19 promoter and represses its transcription, suppressing colon cancer stem cell stemness and promoting differentiation via the LncRNA-H19/miR-141/β-catenin pathway; LncRNA-H19 mediates Sohlh2 effects on CSC stemness.\",\n      \"method\": \"ChIP and luciferase reporter for H19 promoter, LncRNA-H19 rescue/knockdown epistasis, in vitro and in vivo CSC assays\",\n      \"journal\": \"Molecular cancer research : MCR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay for direct binding, epistasis rescue, in vivo validation, single lab\",\n      \"pmids\": [\"36287177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SOHLH2 promotes hepatocellular carcinoma progression by directly binding the TGM2 promoter and enhancing its transcriptional activity, thereby promoting autophagy of HCC cells.\",\n      \"method\": \"Sohlh2 overexpression/knockdown in HCC lines, ChIP and reporter assay for TGM2 promoter, in vitro and in vivo proliferation/migration/invasion assays\",\n      \"journal\": \"Molecular carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay for direct promoter binding, in vivo validation, single lab\",\n      \"pmids\": [\"39436118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"PRMT5 mediates arginine methylation of SOHLH2 in vascular endothelial cells, promoting CUL4B-mediated ubiquitylation and degradation of SOHLH2; SOHLH2 in turn promotes Sirt1 transcription and represses NF-κB signaling, suppressing endothelial cell senescence, permeability, and TNBC trans-endothelial migration.\",\n      \"method\": \"Tissue microarray, Sohlh2 endothelial-specific knock-in mouse, co-IP for PRMT5-SOHLH2 and CUL4B interactions, ubiquitination assay, ChIP/reporter assay for Sirt1 promoter, in vivo lung metastasis model\",\n      \"journal\": \"Advanced science (Weinheim, Baden-Wurttemberg, Germany)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific knock-in, in vivo model, ubiquitination assay, ChIP for direct target, co-IP for post-translational modification complex; single lab, abstracts only\",\n      \"pmids\": [\"41867089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"SOHLH2 transcriptionally activates RAD54L expression by binding its promoter, promoting homologous recombination repair of DNA double-strand breaks and conferring radioresistance in NSCLC; RAD54L overexpression rescues the suppression of HR repair caused by SOHLH2 knockdown.\",\n      \"method\": \"SOHLH2 overexpression/knockdown in NSCLC cells, ChIP/reporter assay for RAD54L promoter, HR repair assay, RAD54L rescue experiment, in vitro and in vivo radioresistance assays\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis rescue by RAD54L re-expression, ChIP for direct target, multiple functional readouts, single lab\",\n      \"pmids\": [\"41535248\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SOHLH2 is a germ cell-specific bHLH transcription factor that heterodimerizes with SOHLH1 (and homodimerizes), with nuclear translocation dependent on SOHLH1; together they directly bind E-boxes in target promoters to regulate Kit, Gfra1, Sox3, Sycp1, Stra8, and Sohlh1 transcription, coordinating spermatogonial differentiation and synaptonemal complex formation downstream of BMP4/Smad signaling and upstream of c-kit/PI3K/Akt/Foxo3a survival signaling; in somatic cancer contexts, SOHLH2 acts as a context-dependent transcription factor that represses oncogenic targets (MMP9, IL-8, HIF1α, cyclin D1, LXRα, H19, HIF1α/CA9) or activates tumor-suppressive targets (p21, APC, p62, Sirt1, RAD54L), and its stability is controlled by TRIM21- and CUL4B-mediated ubiquitination downstream of PRMT5-catalyzed arginine methylation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SOHLH2 is a germ cell-specific basic helix-loop-helix (bHLH) transcription factor that governs premeiotic germ cell differentiation and, in somatic tissues, acts as a context-dependent transcriptional regulator of proliferation, invasion, and stress responses [#0, #1]. In the male germline, SOHLH2 is required for progression of differentiating type A spermatogonia to type B; its loss arrests differentiation and deranges cell-surface cKit expression [#1]. It functions in obligate partnership with SOHLH1: the two factors heterodimerize (and SOHLH2 can homodimerize), are mutually co-expressed across the spermatogonial population, and act synergistically, with SOHLH2 nuclear translocation depending on SOHLH1 [#2, #3, #15]. Together they bind E-box motifs to directly activate Kit—cooperatively transactivating its promoter and first intron—and to auto-regulate Sohlh1 transcription through a ternary complex with SP1, while repressing the SSC-maintenance and meiotic-entry programs by suppressing Gfra1, Sox3, and Stra8 [#3, #5, #7, #10]. SOHLH2 acts downstream of BMP4/SMAD signaling and upstream of cKit, and protects oocytes from apoptosis via a cKit/PI3K/Akt/Foxo3a axis [#6, #8, #11]. SOHLH2 is also essential for synaptonemal complex formation, directly binding and activating the Sycp1 promoter [#13]. In cancer and somatic disease contexts, SOHLH2 binds target promoters to repress oncogenic and pro-invasive genes—MMP9, IL-8, HIF1\\u03b1, cyclin D1, LXR\\u03b1, H19—and to activate tumor-suppressive genes including p21 and APC, with epistasis confirming these targets mediate its anti-proliferative, anti-invasive, and anti-angiogenic effects [#9, #12, #14, #16, #18, #22]. SOHLH2 protein abundance is set by ubiquitin-mediated degradation, with TRIM21 and PRMT5-directed CUL4B promoting its turnover [#20, #24].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Established SOHLH2's identity and expression niche, defining it as a germ cell-restricted bHLH factor confined to premeiotic spermatogonia and oocytes.\",\n      \"evidence\": \"Expression analysis and IHC across mouse gonad development\",\n      \"pmids\": [\"16765102\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional assay or target genes in this study\", \"DNA-binding activity not demonstrated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined the in vivo requirement for SOHLH2 in spermatogonial differentiation, showing knockout males arrest at type A2 spermatogonia with aberrant cKit, linking the factor to the cKit differentiation program.\",\n      \"evidence\": \"Sohlh2 knockout mouse with histology, marker immunostaining, and cultured spermatogonia cKit analysis\",\n      \"pmids\": [\"18339773\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets not yet identified\", \"Mechanism of cKit deregulation unresolved at this stage\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified SOHLH1 as a SOHLH2 partner and showed SOHLH2 controls Sohlh1 levels, introducing the heterodimer model for KIT+ germ cell differentiation.\",\n      \"evidence\": \"Co-IP for heterodimerization, knockout, and Sohlh1 expression analysis\",\n      \"pmids\": [\"19014927\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct promoter binding not shown\", \"Whether dimerization is required for DNA binding unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Resolved the dimerization architecture and the dual regulatory logic, demonstrating in vivo hetero- and homodimerization and direct, synergistic regulation of Gfra1, Sox3, and Kit to suppress SSC maintenance and induce differentiation.\",\n      \"evidence\": \"In vivo reciprocal co-IP, double-knockout genetic epistasis, immunostaining, and gene expression analysis\",\n      \"pmids\": [\"22056784\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E-box occupancy at Gfra1/Sox3 not directly mapped here\", \"Repression versus activation mechanism not biochemically distinguished\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed SOHLH2 transcription is itself epigenetically gated, with dynamic promoter CpG methylation tracking its expression during gametogenesis.\",\n      \"evidence\": \"Bisulfite sequencing of promoter/exon/intron loci correlated with transcript levels\",\n      \"pmids\": [\"21427160\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal link between methylation and expression not tested by functional rescue\", \"Enzymes establishing the methylation not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Provided direct biochemical proof that SOHLH1/SOHLH2 bind Kit promoter and intronic E-boxes and cooperatively transactivate Kit, establishing Kit as a bona fide direct target.\",\n      \"evidence\": \"Reporter assays, EMSA, ChIP in spermatogonia, co-IP, and ES cell overexpression\",\n      \"pmids\": [\"22328502\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Independent versus cooperative contributions of each factor not fully separated\", \"Co-activator requirements not defined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Placed SOHLH2 within an upstream BMP4/SMAD signaling input controlling the primordial-to-primary follicle transition.\",\n      \"evidence\": \"Ovarian organ culture with BMP4, IHC, RT-PCR, and pSMAD Western blotting\",\n      \"pmids\": [\"23212987\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No knockout or rescue in this system\", \"Direct SMAD action on the Sohlh2 promoter not demonstrated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Uncovered an auto-regulatory loop in which SOHLH2/SOHLH1 and SP1 form a ternary complex to activate Sohlh1 transcription, explaining mutual dependence of the two factors.\",\n      \"evidence\": \"Reporter/transactivation assays, SOHLH1-SP1 co-IP, and in vivo ChIP in postnatal testes\",\n      \"pmids\": [\"25003626\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SOHLH2 contacts SP1 directly not resolved\", \"Stoichiometry of the ternary complex unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Confirmed the BMP4/Smad \\u2192 Sohlh2 \\u2192 cKit epistatic order in SSC differentiation through pathway inhibition and RNAi.\",\n      \"evidence\": \"BMP4 treatment, dorsomorphin inhibition, and Sohlh2 siRNA in cultured SSCs\",\n      \"pmids\": [\"24591295\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional connection to cKit in SSCs not re-mapped here\", \"In vivo relevance of the inhibitor effect untested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Opened the somatic/oncogenic chapter, defining SOHLH2 as an ovarian cancer tumor suppressor acting through direct p21 upregulation and cyclin D1 downregulation.\",\n      \"evidence\": \"Gain/loss of function, proliferation assays, xenografts, and p21/cyclin D1 siRNA epistasis\",\n      \"pmids\": [\"24858206\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct promoter occupancy at p21/cyclin D1 not shown here\", \"Mechanism switching SOHLH2 between activation and repression unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Extended the germline regulatory network by showing SOHLH factors cooperatively repress Stra8 via E-boxes, linking them to control of meiotic entry timing.\",\n      \"evidence\": \"Reporter assays with E-box mutagenesis and expression analysis in KIT+ spermatogonia\",\n      \"pmids\": [\"25603532\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo ChIP at the Stra8 promoter not reported\", \"Repressive co-factors not identified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined the survival pathway by which SOHLH2 protects oocytes, the cKit/PI3K/Akt/Foxo3a anti-apoptotic axis.\",\n      \"evidence\": \"siRNA/overexpression in oocyte cultures, P-Akt/Foxo3a Western blots, LY294002 rescue, and TUNEL\",\n      \"pmids\": [\"25773528\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional step linking SOHLH2 to this axis assumed via cKit\", \"In vivo ovarian relevance not tested in this study\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showed SOHLH2 suppresses cancer invasion through direct repression of MMP9, the first promoter-level anti-invasive target.\",\n      \"evidence\": \"Reporter/binding assays, MMP9 siRNA and ectopic MMP9 epistasis, invasion assays, and metastasis model\",\n      \"pmids\": [\"26153894\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-repressor machinery undefined\", \"Single-cancer-type validation\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified an independent meiotic role for SOHLH2 in synaptonemal complex formation through direct activation of Sycp1.\",\n      \"evidence\": \"Knockout phenotyping, SYCP3 immunostaining/Western, and Sycp1 promoter reporter with E-box analysis\",\n      \"pmids\": [\"26869299\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether SOHLH1 partnership is required here not resolved\", \"Direct regulation of other SC components not tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Expanded anti-invasive function to breast cancer EMT via direct repression of IL-8.\",\n      \"evidence\": \"ChIP, luciferase reporter, RNA-seq, IL-8 siRNA/recombinant IL-8 rescue, and metastasis model\",\n      \"pmids\": [\"27384482\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cross-talk among repressed invasion targets not integrated\", \"Determinants of target selectivity unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established SOHLH1-dependent nuclear translocation of SOHLH2 and defined its earliest embryonic germline activity, refining the temporal hierarchy of the two factors.\",\n      \"evidence\": \"Confocal localization in embryonic gonads, Sohlh1 KO localization analysis, and KO expression of LHX8/NOBOX\",\n      \"pmids\": [\"28504655\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of SOHLH1-dependent nuclear import unknown\", \"Whether cytoplasmic SOHLH2 has non-genomic roles untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed SOHLH2 restrains Wnt/\\u03b2-catenin signaling by directly activating APC, adding a tumor-suppressive activation target.\",\n      \"evidence\": \"Forced expression/knockdown, proliferation/cell-cycle assays, xenograft, and APC siRNA epistasis\",\n      \"pmids\": [\"30720232\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct APC promoter occupancy not shown\", \"Reconciliation with H19/\\u03b2-catenin pathway in colon cancer not addressed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Linked SOHLH2 to hypoxic invasion control via the HIF1\\u03b1/CA9 axis in ovarian cancer.\",\n      \"evidence\": \"Overexpression/knockdown under hypoxia with migration/invasion assays and HIF1\\u03b1/CA9 Western blot\",\n      \"pmids\": [\"31318683\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct promoter binding or rescue in this study\", \"Pathway placement rests on expression changes only\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Provided direct evidence that SOHLH2 represses angiogenesis by binding and repressing the HIF1\\u03b1 promoter.\",\n      \"evidence\": \"ChIP, luciferase reporter, HUVEC co-culture, xenograft MVD, and HIF1\\u03b1 rescue\",\n      \"pmids\": [\"34158392\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relationship to HIF1\\u03b1/CA9 invasion findings not unified\", \"Hypoxia-dependence of SOHLH2 binding untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Proposed an epigenetic tumor-suppressive route in renal cancer via DNMT3a downregulation and Klotho demethylation.\",\n      \"evidence\": \"Overexpression/knockdown in RCC lines, DNMT3a/Klotho qPCR-Western, proliferation, xenograft, and patient IHC\",\n      \"pmids\": [\"35127476\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct methylation assay or ChIP for DNMT3a regulation\", \"Mechanism inferred from expression correlation\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Connected SOHLH2 to tumor immune microenvironment, showing it drives macrophage M2 polarization via direct LXR\\u03b1 activation, and identified TRIM21 as an E3 ligase controlling SOHLH2 turnover.\",\n      \"evidence\": \"Macrophage overexpression, ChIP/reporter for LXR\\u03b1, TRIM21 co-IP and ubiquitination assays, and lung metastasis model\",\n      \"pmids\": [\"38123542\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Degron and ubiquitination sites on SOHLH2 not mapped\", \"Reconciliation with tumor-suppressive roles context-dependent and unexplained\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrated SOHLH2 modulates oxidative stress in pulmonary fibrosis by directly repressing p62 and dampening Keap1/Nrf2 signaling.\",\n      \"evidence\": \"Type II AEC conditional knock-in mouse, A549 overexpression, ROS/apoptosis assays, NAC rescue, and p62 promoter analysis\",\n      \"pmids\": [\"37875506\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ChIP at the p62 promoter not detailed\", \"Relevance beyond AEC unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed SOHLH2 suppresses cancer stem cell stemness by directly repressing the LncRNA-H19 promoter, feeding the H19/miR-141/\\u03b2-catenin axis.\",\n      \"evidence\": \"ChIP, luciferase reporter, H19 rescue/knockdown epistasis, and in vitro/in vivo CSC assays\",\n      \"pmids\": [\"36287177\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Integration with APC-mediated Wnt control not addressed\", \"Determinants of repression vs activation at different promoters unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Documented a pro-tumorigenic activity in hepatocellular carcinoma, with SOHLH2 directly activating TGM2 to promote autophagy and progression, underscoring context dependence.\",\n      \"evidence\": \"Overexpression/knockdown, ChIP/reporter for TGM2, and in vitro/in vivo tumor assays\",\n      \"pmids\": [\"39436118\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Basis for tumor-promoting versus tumor-suppressing switch unresolved\", \"Upstream control of SOHLH2 in HCC undefined\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Defined post-translational control of SOHLH2 by PRMT5-directed arginine methylation and CUL4B-mediated degradation, coupled to a Sirt1-activating, NF-\\u03baB-repressing endothelial program.\",\n      \"evidence\": \"Endothelial knock-in mouse, PRMT5/CUL4B co-IP, ubiquitination assay, Sirt1 ChIP/reporter, and lung metastasis model\",\n      \"pmids\": [\"41867089\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Methylated arginine residues not mapped\", \"Interplay between TRIM21 and CUL4B degradation routes unresolved\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Linked SOHLH2 to DNA double-strand break repair, showing it activates RAD54L to promote homologous recombination and radioresistance in lung cancer.\",\n      \"evidence\": \"Overexpression/knockdown, ChIP/reporter for RAD54L, HR repair assay, RAD54L rescue, and radioresistance models\",\n      \"pmids\": [\"41535248\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether HR role extends to germ cell meiotic recombination untested\", \"Relationship to SOHLH2 degradation control unexamined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular determinant that switches SOHLH2 between direct transcriptional activation and repression, and between tumor-suppressive and tumor-promoting outputs across tissues, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of SOHLH2 DNA binding or cofactor selection\", \"Co-activator/co-repressor partners that dictate target outcome unidentified\", \"Integration of TRIM21 and PRMT5/CUL4B degradation pathways into a unified stability model lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 3, 5, 7, 9, 12, 14, 18, 22, 23, 25]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [5, 7, 10, 13, 18, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 15]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [5, 7, 9, 12, 14, 18, 22, 23, 25]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [1, 3, 13]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 8, 11, 16]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 15]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [9, 12, 14, 18, 20, 24]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [25]}\n    ],\n    \"complexes\": [\n      \"SOHLH1-SOHLH2 heterodimer\",\n      \"SOHLH2/SOHLH1/SP1 ternary complex\"\n    ],\n    \"partners\": [\n      \"SOHLH1\",\n      \"SP1\",\n      \"TRIM21\",\n      \"PRMT5\",\n      \"CUL4B\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}